Skip to Main Content

Author Details

George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
1970
254
69
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35105718Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study.Clin Cancer Res2022
36239623Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.Clin Cancer Res2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
35852875An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases.JCI Insight2022
35105718Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study.Clin Cancer Res2022
35852875An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases.JCI Insight2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36239623Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.Clin Cancer Res2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
30888548Cancer Explant Models.Curr Top Microbiol Immunol2021
33741928The transcriptional landscape of Shh medulloblastoma.Nat Commun2021
33524948Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas.Neurosurg Focus2021
33838625Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.N Engl J Med2021
33720050N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.J Clin Invest2021
34321569Positron emission tomography imaging with <sup>89</sup>Zr-labeled anti-CD8 cys-diabody reveals CD8<sup>+</sup> cell infiltration during oncolytic virus therapy in a glioma murine model.Sci Rep2021
33391498Glioma stem cells and their roles within the hypoxic tumor microenvironment.Theranostics2021
34625579Author Correction: Positron emission tomography imaging with <sup>89</sup>Zr-labeled anti-CD8 cys-diabody reveals CD8<sup>+</sup> cell infiltration during oncolytic virus therapy in a glioma murine model.Sci Rep2021
34548489SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.Nat Commun2021
34702850A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas.Sci Rep2021
35342877Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus.J Transl Genet Genom2021
30888548Cancer Explant Models.Curr Top Microbiol Immunol2021
35342877Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus.J Transl Genet Genom2021
33720050N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.J Clin Invest2021
33741928The transcriptional landscape of Shh medulloblastoma.Nat Commun2021
33838625Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.N Engl J Med2021
33524948Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas.Neurosurg Focus2021
34702850A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas.Sci Rep2021
34548489SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.Nat Commun2021
34625579Author Correction: Positron emission tomography imaging with <sup>89</sup>Zr-labeled anti-CD8 cys-diabody reveals CD8<sup>+</sup> cell infiltration during oncolytic virus therapy in a glioma murine model.Sci Rep2021
34321569Positron emission tomography imaging with <sup>89</sup>Zr-labeled anti-CD8 cys-diabody reveals CD8<sup>+</sup> cell infiltration during oncolytic virus therapy in a glioma murine model.Sci Rep2021
33391498Glioma stem cells and their roles within the hypoxic tumor microenvironment.Theranostics2021
30918335Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice.Cancer Gene Ther2020
31773232Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models.Eur J Nucl Med Mol Imaging2020
32657154Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.Hum Gene Ther2020
33077834A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.Oncogene2020
33126510Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential.Cells2020
33005623The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas.Front Surg2020
30918335Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice.Cancer Gene Ther2020
31773232Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models.Eur J Nucl Med Mol Imaging2020
33077834A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.Oncogene2020
33126510Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential.Cells2020
33005623The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas.Front Surg2020
32657154Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.Hum Gene Ther2020
30481622Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus -1 G207 in Pediatric Malignant Supratentorial Brain Tumors.World Neurosurg2019
30460631Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis.J Neurooncol2019
30481622Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus -1 G207 in Pediatric Malignant Supratentorial Brain Tumors.World Neurosurg2019
30629778Chromodomain Helicase DNA-Binding Protein 7 Is Suppressed in the Perinecrotic/Ischemic Microenvironment and Is a Novel Regulator of Glioblastoma Angiogenesis.Stem Cells2019
31336733A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening.Cells2019
30942445Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.Int J Oncol2019
  • 1 - 50 of 508

Recommended Authors

Westlake University
Career Start Year 2009
Number of shared co-authors 13
Northwestern University
Career Start Year 2005
Number of shared co-authors 2
Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 11
CIMA-Universidad de Navarra
Career Start Year 2001
Number of shared co-authors 41
Johannes Kepler University
Career Start Year 2001
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 51
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 7
Regeneron Pharmaceuticals Inc.
Career Start Year 1994
Number of shared co-authors 2
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 3
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 1
Telethon Kids Institute
Career Start Year 1990
Number of shared co-authors 8
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 7
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Career Start Year 1990
Number of shared co-authors 3
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 8
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 4
Northwestern University Feinberg School of Medicine
Career Start Year 1988
Number of shared co-authors 7
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 8
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 41
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 1
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 6
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 29
Virginia Commonwealth University
Career Start Year 1977
Number of shared co-authors 1
University of California san francisco
Career Start Year 1975
Number of shared co-authors 35
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 25
Henry Ford Hospital
Career Start Year 1973
Number of shared co-authors 4
University of Colorado School of Medicine
Career Start Year 1961
Number of shared co-authors 1
Mount Sinai Hospital
Career Start Year 1943
Number of shared co-authors 72

Collaborators

University of Alabama at Birmingham
Co-authored papers 20
University of Alabama at Birmingham
Co-authored papers 13
Co-authored papers 9
The Hospital for Sick Children
Co-authored papers 9
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 8
University of Alabama at Birmingham
Co-authored papers 8
Co-authored papers 8
University of Alabama at Birmingham
Co-authored papers 8
Virginia Commonwealthy University
Co-authored papers 7
Children's Memorial Health Institute
Co-authored papers 7
The Hospital for Sick Children, University of Toronto
Co-authored papers 6
St. Jude Children's Research Hospital
Co-authored papers 6
University of Pittsburgh School of Medicine
Co-authored papers 6
McMaster University
Co-authored papers 6
Dana-Farber Cancer Institute
Co-authored papers 6
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 6
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 6
Co-authored papers 6
Cumming School of Medicine, University of Calgary
Co-authored papers 6
Hospital for Sick Children
Co-authored papers 6
Seoul National University Children's Hospital
Co-authored papers 6
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 6
Hospital for Sick Children
Co-authored papers 5
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 5
Institut Curie, PSL Research University
Co-authored papers 5
University of California san francisco
Co-authored papers 5
Erasmus MC Cancer Institute
Co-authored papers 5
Kitasato University School of Medicine
Co-authored papers 5
University of Wollongong
Co-authored papers 5
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 5